共 50 条
- [41] TAXUS II paclitaxel-eluting stent trial: 2 year intravascular ultrasound substudy[J]. CIRCULATION, 2004, 110 (17) : 527 - 527Banning, ADudek, DDrzewiecki, JZmudka, KSchiele, FKoglin, J
- [42] Early and late stent thrombosis after paclitaxel-eluting stents: Analysis from the integrated TAXUS randomized trial program[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 221A - 221AEllis, SGColombo, AGrube, EPopma, JKoglin, JRussell, MStone, GW
- [43] A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease[J]. HERZ, 2009, 34 (08) : 651 - 651Bergmann, M. W.
- [44] A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions 12-Month Outcomes From the ENDEAVOR IV Trial[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (06) : 543 - 554Leon, Martin B.Mauri, LauraPopma, Jeffrey J.Cutlip, Donald E.Nikolsky, EugeniaO'Shaughnessy, CharlesOverlie, Paul A.McLaurin, Brent T.Solomon, Stuart L.Douglas, John S., Jr.Ball, Michael W.Caputo, Ronald P.Jain, AshTolleson, Thaddeus R.Reen, Bernard M., IIIKirtane, Ajay J.Fitzgerald, Peter J.Thompson, KweliKandzari, David E.
- [45] Paclitaxel increases the length of stent that is free of intimal hyperplasia: An intravascular ultrasound analysis from TAXUS-IV and TAXUS-VI[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 88A - 89AEscolar, EMintz, GSKoglin, JLam, PPompa, JJRussell, MGrube, EDawkins, KEllis, SStone, GWWeissman, NJ
- [46] COMPARISON OF THE EFFICACY AND SAFETY OF PACLITAXEL-ELUTING COROFLEXTM PLEASE STENT VERSUS PACLITAXEL-ELUTING STENT IN PATIENTS WITH CORONARY ARTERY DISEASE: THE PIPA RANDOMIZED CONTROLLED TRIAL[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1837 - E1837Kim, Young-HakKim, Hyun-SookPark, Duk-WooCheong, Sang-SigLee, Bong-KiLee, Seung-WookLee, KeunLee, Nae-HeeLee, Sang-GonLee, Chang HoonHwang, Ki WonPark, Gyung-MinKim, Yong-GiunAhn, Jung-MinSong, Hae GeunKim, Won-JangLee, Jong-YoungKang, Soo-JinLee, Seung-WhanLee, Cheol WhanPark, Seong-WookPark, Seung-Jung
- [47] Risks and benefits of the paclitaxel-eluting TAXUS stent in large vessels: Results from the 4.0 mm stent subgroup of the TAXUS-V trial[J]. CIRCULATION, 2005, 112 (17) : U613 - U613Cannon, LAEllis, SGChang, MJacobs, CBrown, CKieval, JTurco, MIyer, SSKoglin, JStone, GW
- [48] A paclitaxel-eluting stent for the prevention of coronary restenosis[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (16): : 1537 - 1545Park, SJShim, WHHo, DSRaizner, AEPark, SWHong, MKLee, CWChoi, DHJang, YSLam, RWeissman, NJMintz, GS
- [49] Comparison of Dual Drug-Eluting Cilotax Stent and Paclitaxel-Eluting Taxus Liberte Stent in Native Coronary Artery Lesions[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (07): : 990 - 994Lee, Cheol WhanPark, Duk-WooSeung, Ki BaeKim, Pum JoonPark, Hun JoonKim, Won-JangLee, Jong YoungKang, Soo-JinLee, Seung-HwanKim, Young-HakPark, Seong-WookPark, Seung-Jung
- [50] Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberte Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries The NOBORI 1 Trial - Phase 2[J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (03) : 188 - U57Chevalier, BernardSilber, SigmundPark, Seung-JungGarcia, EulogioSchuler, GerhardSuryapranata, HarryKoolen, JacquesHauptmann, Karl E.Wijns, WilliamMorice, Marie-ClaudeCarrie, Didiervan Es, Gerrit-AnneNagai, HirofumiDetiege, DannyPaunovic, DragicaSerruys, Patrick W.